Reaction Details |
| Report a problem with these data |
Target | Leukotriene B4 receptor 1 |
---|
Ligand | BDBM32020 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | ChEBML_98491 |
---|
IC50 | 85±n/a nM |
---|
Citation | Lau, CK; Bélanger, PC; Dufresne, C; Scheigetz, J; Therien, M; Fitzsimmons, B; Young, RN; Ford-Hutchinson, AW; Riendeau, D; Denis, D Development of 2,3-dihydro-6-(3-phenoxypropyl)-2-(2-phenylethyl)-5-benzofuranol (L-670,630) as a potent and orally active inhibitor of 5-lipoxygenase. J Med Chem35:1299-318 (1992) [PubMed] |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Leukotriene B4 receptor 1 |
---|
Name: | Leukotriene B4 receptor 1 |
Synonyms: | BLT | BLT1 | BLTR | CMKRL1 | Chemoattractant receptor-like 1 | G-protein coupled receptor 16 | GPR16 | LT4R1_HUMAN | LTB4-R 1 | LTB4R | Leukotriene B4 R1 | Leukotriene B4 receptor | Leukotriene B4 receptor 1 | P2RY7 | P2Y purinoceptor 7 | P2Y7 |
Type: | Enzyme Catalytic Domain |
Mol. Mass.: | 37582.68 |
Organism: | Homo sapiens (Human) |
Description: | Q15722 |
Residue: | 352 |
Sequence: | MNTTSSAAPPSLGVEFISLLAIILLSVALAVGLPGNSFVVWSILKRMQKRSVTALMVLNL
ALADLAVLLTAPFFLHFLAQGTWSFGLAGCRLCHYVCGVSMYASVLLITAMSLDRSLAVA
RPFVSQKLRTKAMARRVLAGIWVLSFLLATPVLAYRTVVPWKTNMSLCFPRYPSEGHRAF
HLIFEAVTGFLLPFLAVVASYSDIGRRLQARRFRRSRRTGRLVVLIILTFAAFWLPYHVV
NLAEAGRALAGQAAGLGLVGKRLSLARNVLIALAFLSSSVNPVLYACAGGGLLRSAGVGF
VAKLLEGTGSEASSTRRGGSLGQTARSGPAALEPGPSESLTASSPLKLNELN
|
|
|
BDBM32020 |
---|
n/a |
---|
Name | BDBM32020 |
Synonyms: | 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethyl-butyl]pyrocatechol | 4-[4-(3,4-dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol | 4-[4-[3,4-bis(oxidanyl)phenyl]-2,3-dimethyl-butyl]benzene-1,2-diol | BDBM166684 | CHEMBL52 | LOX inhibitor, N/A | MLS000069451 | NORDIHYDROGUAIARETIC ACID | Nordihydroguaiaretic acid (NDGA) | SMR000059049 | US10857082, Compound 2.18 | cid_4534 |
Type | Small organic molecule |
Emp. Form. | C18H22O4 |
Mol. Mass. | 302.3649 |
SMILES | CC(Cc1ccc(O)c(O)c1)C(C)Cc1ccc(O)c(O)c1 |
Structure |
|